Dark

GILD
Gilead Sciences Inc
stock NASDAQ

At Close

May 15, 2026 3:59:59 PM EDT

129.59USD-1.870%(-2.47)6,641,026

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 15, 2026 9:29:30 AM EDT

132.62USD+0.424%(+0.56)8,143

After-hours

May 15, 2026 4:18:30 PM EDT

129.58USD-0.008%(-0.01)1,653,167

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

160.90B

Headquarters

Foster City, California, USA

Industry

Drug Manufacturers-General

Last Dividend

Mar 13, 20260.820

Last Split

Jan 28, 20132for1

AMGN ALXN CELG VRTX ILMN BIIB JNJ LLY MRK ABBV XLV

GILD Stats

Avg. Vol. 10 Day

6,679,659

Avg. Vol. 30 Day

5,788,657

Employees

10,000

Market Cap

160,895,039,972

Shares Out.

1,241,569,874

On/Off Exchange

55%/45%

6 Month Beta

0.59

1 Year Beta

0.52

2 Year Beta

0.35

3 Year Beta

0.36

52 Week Low

100.23

52 Week High

157.29

SMA50

137.35

SMA200

127.85

1 Week

-1.33%

1 Month

-6.47%

3 Month

-16.54%

6 Month

+4.43%

1 Year

+26.43%

2 Year

+90.97%

5 Year

+87.62%

Profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

GILD Stock Summary

Gilead Sciences Inc (NASDAQ:GILD) stock price today is $129.59, and today's volume is 6,641,026. GILD is down -1.870% today. The 30 day average volume is 5,788,657. GILD market cap is 160.90B with 1,241,569,874 shares outstanding.

document.getElementById("ZY0Bgt").onerror = function(){this.style.display='none';}; .dark-mode .DMv8fW{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .DMv8fW{ color: #333333; background-color: white; border: 2px solid #333333; }GILDGilead Sciences Incstock NASDAQ

GILD Stock Summary

GILD
Gilead Sciences Inc
stock NASDAQ